May 9 (Reuters) - Bain Capital is in talks to buy contract drug manufacturer PCI Pharma Services at a valuation of $10 billion, Bloomberg News reported on Friday, citing people familiar with the ...
Steve Pagliuca, Bain Capital chairperson, joins 'Money Movers' to discuss private equity's entrance into the NFL, private equity's conflicting interests, and much more. Got a confidential news tip? We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results